IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Integrated Biopharma Inc (INBP)

CUSIP: 45811V105 | NYSE | 1 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13DDeSantis Damon
with Cdds 2.0, LLC
12,920,55841.3%New 5%+ stakeApr 15, 2026No 13F filer matched
13D/ACD Financial, LLC00.0%No shares held

Institutional Holders — Q3 2025

Moloney Securities Asset Management, LLC20,000
0.0% of portfolio›$5.8K
StyleTurnoverLocationFiled
Moloney Securities Asset Management, LLC
20,000$5.8K0.0%GrowthMediumManchester, MO2025-11-05
Apr 15, 2026
No 13F filer matched
13DDeSantis Damon12,920,558
41.3% of class · Apr 15, 2026New 5%+ stake
with Cdds 2.0, LLC
No 13F filer matched
13D/ACD Financial, LLC0
0.0% of class · Apr 15, 2026No shares held
No 13F filer matched